2005 Publications - 2005 Publications (Part III)

Poster presentations: 2005

Gray GE, McIntyre JA, Martinson N, Hopley M, Hall D, Mayers D for the Treatment Options (TOPS) Trial/1413 Investigator Team. NNRTI-resistant mutations in HIV-infected infants following single dose nevirapine (sd-NVP) are reduced by the addition of short course zidovudine and 3TC. 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Heyer AS, Rowe K, Makhubela BM, Hargreaves JR, Porter JDH, Haussler HP, Pronyk PM. Preparing for Antiretroviral Therapy: lessons learned through the provision of TB preventative therapy for HIV positive patients in rural South Africa. South African AIDS conference, Durban, August 2003.

Heyer A, Steyn J, Pronyk P, McIntryre J, Gray G, Struthers H and Martinson N, Prevalence and risk factors for pre-malignant cervical lesions in HIV infected women? 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Martinson N, Heyer A, Steyn J, Struthers H, McIntyre J, Gray G, Pronyk P. Does WHO clinical stage reliably predict who should receive ARV treatment? Abstract WeFO0304 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Mast TC, Kierstead L, Gupta S, Nikas A, Kallas E, Novitsky V, Mbewe B, Pitisuttithum, Schecter M, Vardas E, Wolfe N, Aste-Amezaga, Shriver J, Coplan P, Straus W. Epidemiology of human pre-existing anti-adenovirus type-6 (AD6) and type-5 (AD5) neutralizing antibodies (NA) in areas representative of potential HIV vaccine trial sites. (304P). AIDS Vaccine Conference, Montreal, September 6-9, 2005.

McIntyre J, Martinson N, Gray GE for the Treatment Options (TOPS) Trial/1413 Investigator Team, Single dose nevirapine combined with a short course of combivir for prevention of mother to child transmission of HIV-1 can significantly decrease the subsequent development of maternal and infant resistant virus. 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Mesesan K, Mlungwana O, Van Niekerk R, Gray G, McIntyre J, Niccolai L, Vardas E. Self-reported risk behaviours of a cohort undergoing screening and enrolment into multiple phase I/II HIV vaccine trials in Soweto, South Africa. (351P). AIDS Vaccine Conference, Montreal, September 6-9, 2005.

Mohlahlane R, Crewe M, Brouard P, Maritz J, Vardas E, Bogoshi M. “Finding the way”: A process of preparing communities for AIDS vaccine trials in a developing country. (602P). AIDS Vaccine Conference, Montreal, September 6-9, 2005.

Struthers HE, McIntyre JA, James KH and Whiting SA, A model of support for antiretroviral treatment in rural South Africa. 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Vardas E, Mlungwana O, Van Niekirk R, Mesesan K, Mogale M, Mayaphi S, McIntyre J, Gray G. Characteristics of a cohort of individuals screened for phase I/II HIV vaccine trials in South Africa. (344P). AIDS Vaccine Conference, Montreal, September 6-9, 2005.